Education
About Us
Working with TipRanks
Follow Us
Robert W Moses Insider Profile
4 Followers
Robert W Moses, Director at Percheron Therapeutics, holds 9.09M shares in Percheron Therapeutics (Ticker: PERCF). Most recently, Robert W Moses Bought 278,928 shares of Percheron Therapeutics on Jul 26, 2018 for an estimated value of $7.25K.
Robert W Moses Percheron Therapeutics (PERCF)Director
Percheron Therapeutics (PERCF)
Director
Ranked #91,971 out of 106,131 Corporate Insiders
Profitable Transactions
3 out of 14 Profitable Transactions
Average Return
-17.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert W Moses's holdings
Insider Roles
Director
Roles that Robert W Moses holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 26, 2018 - Jul 26, 2019
Return:+54.50%
The most profitable trade made by Robert W Moses
Robert W Moses's Trading History
List of latest transactions for each holding click on a transaction to see Robert W Moses's performance on stock
You May Also Like
Robert W Moses insider profile FAQ
What is the percentage of profitable transactions made by Robert W Moses?
The percentage of profitable transactions made by Robert W Moses is 21%.
What is the average return per transaction made by Robert W Moses?
The average return per transaction made by Robert W Moses is -17.20%.
What stocks does Robert W Moses hold?
Robert W Moses holds: PERCF stocks.
What was Robert W Moses’s latest transaction?
Robert W Moses latest transaction was an Informative Buy of $7.25K.
What was Robert W Moses's most profitable transaction?
Robert W Moses’s most profitable transaction was an Informative Buy of PERCF stock on July 26, 2018. The return on the trade was 54.50%.
What is Robert W Moses's role in Percheron Therapeutics?
Robert W Moses's role in Percheron Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.